Explore Gained Favor, Extended Period and more!

Explore related topics

ACAD Chart An $8 #BillionHedgeFund Bought This #ExtremelyRiskyStock GeorgeBudwell |@themotelyFool @deerwalkinc @Synageva is lookingtobecome a #leaderintheorphandrugspace #Drugsforrarediseases have gained favor in the #pharmaceuticalindustry because theyoffer theirmanufacturersseveralkey #advantagesovertreatmentsformorecommonconditions, such as an extended period of marketexclusivity, taxcredits, fasterreviewtimes, and even a waiverofsomeregulatoryfees.   #rarediseasedrugmakers@BioMarin

ACAD Chart An $8 #BillionHedgeFund Bought This #ExtremelyRiskyStock GeorgeBudwell |@themotelyFool @deerwalkinc @Synageva is lookingtobecome a #leaderintheorphandrugspace #Drugsforrarediseases have gained favor in the #pharmaceuticalindustry because theyoffer theirmanufacturersseveralkey #advantagesovertreatmentsformorecommonconditions, such as an extended period of marketexclusivity, taxcredits, fasterreviewtimes, and even a waiverofsomeregulatoryfees. #rarediseasedrugmakers@BioMarin

Pinterest
Search